↑ Grab this Headline Animator

Clinical Trial On Dysfunctional Uterine Bleeding DUB Now Conducted...

The Center for Women's Care & Reproductive Surgery, headed by laparoscopic pioneer Thomas L. Lyons, MD, is conducting a placebo controlled FDA clinical trial on a drug used to control dysfunctional uterine bleeding (DUB).

The anti-fibrinolytic medication stops the body from breaking down clots in the blood, causing heavy bleeding to diminish. It has been demonstrated in Europe to decrease bleeding after being administered during the acute phase of the cycle.

Some women enrolled in the clinical trial will take the drug sporadically through their cycle, whereas some participants will receive the placebo. It is a randomized double-blind study, meaning neither the physician nor the patient knows who is receiving the drug and who is receiving the placebo, to ensure unbiased clinical results. www.ElifeMagazine.net during July 2007.

What Your Doctor Doesn't Tell You

Although Dr. Lyons has trained thousands of surgeons on the LSH technique he developed, most doctors don't perform it.

Some surgeons refuse to perform laparoscopic procedures on a large uterus, and say it can't be done. Left out in that explanation is, "because I can't do it." The size of the uterus is not an issue or a problem for Dr. Lyons.

"It's especially important that patients choose a surgeon who is experienced in working with lasers and laparoscopy. LSH requires more skill than open abdominal hysterectomy. It's easier on the patient, but more challenging for the surgeon," explained Dr. Lyons.

One of the most important factors in helping people choose appropriate medical care is a comprehensive understanding of the reasons for treatment, the risks and the potential benefits. This especially applies to hysterectomy. If hysterectomy has been suggested as an option, women should carefully weigh the pros and cons, the alternative treatments, the potential benefits and risks and the physician's track record.

Many surgeons will attempt a laparoscopic procedure and feel it necessary to convert to an open surgery with a long incision during the procedure. Make sure to ask your surgeon about his or her conversion ratio. Dr. Lyons' conversion ratio is less than one percent.

For information about participation in the trial contact the Center for Women's Care & Reproductive Surgery in Atlanta at 770-352-0037 or toll-free 888-545-0400.

↑ Grab this Headline Animator

---

This article has been robotically scanned and tagged by Prnewsnow with the following search tags. No human manipulation of these tags take place.
| Governance | Governance Risk | |

---

4887 readers online...

, Local News